These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 11431189

  • 1. A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients.
    Thorp ML, Morris CD, Bagby SP.
    Am J Kidney Dis; 2001 Jul; 38(1):104-8. PubMed ID: 11431189
    [Abstract] [Full Text] [Related]

  • 2. Treatment of restless legs syndrome with gabapentin.
    Adler CH.
    Clin Neuropharmacol; 1997 Apr; 20(2):148-51. PubMed ID: 9099467
    [Abstract] [Full Text] [Related]

  • 3. Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study.
    Micozkadioglu H, Ozdemir FN, Kut A, Sezer S, Saatci U, Haberal M.
    Ren Fail; 2004 Jul; 26(4):393-7. PubMed ID: 15462107
    [Abstract] [Full Text] [Related]

  • 4. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.
    Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G.
    Neurology; 2002 Nov 26; 59(10):1573-9. PubMed ID: 12451200
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial.
    Sagheb MM, Dormanesh B, Fallahzadeh MK, Akbari H, Sohrabi Nazari S, Heydari ST, Behzadi S.
    Sleep Med; 2012 May 26; 13(5):542-5. PubMed ID: 22317944
    [Abstract] [Full Text] [Related]

  • 6. Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients: a randomized clinical trial.
    Razazian N, Azimi H, Heidarnejadian J, Afshari D, Ghadami MR.
    Saudi J Kidney Dis Transpl; 2015 Mar 26; 26(2):271-8. PubMed ID: 25758874
    [Abstract] [Full Text] [Related]

  • 7. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K, De S.
    Postgrad Med J; 2013 Jul 26; 89(1053):402-10. PubMed ID: 23524988
    [Abstract] [Full Text] [Related]

  • 8. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin.
    Happe S, Klösch G, Saletu B, Zeitlhofer J.
    Neurology; 2001 Nov 13; 57(9):1717-9. PubMed ID: 11706121
    [Abstract] [Full Text] [Related]

  • 9. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.
    Winkelman JW, Bogan RK, Schmidt MH, Hudson JD, DeRossett SE, Hill-Zabala CE.
    Mov Disord; 2011 Sep 13; 26(11):2065-72. PubMed ID: 21611981
    [Abstract] [Full Text] [Related]

  • 10. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome.
    Happe S, Sauter C, Klösch G, Saletu B, Zeitlhofer J.
    Neuropsychobiology; 2003 Sep 13; 48(2):82-6. PubMed ID: 14504416
    [Abstract] [Full Text] [Related]

  • 11. A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.
    Lal R, Ellenbogen A, Chen D, Zomorodi K, Atluri H, Luo W, Tovera J, Hurt J, Bonzo D, Lassauzet ML, Vu A, Cundy KC.
    Clin Neuropharmacol; 2012 Sep 13; 35(4):165-73. PubMed ID: 22664749
    [Abstract] [Full Text] [Related]

  • 12. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
    Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW, XP052 Study Group.
    Neurology; 2009 Feb 03; 72(5):439-46. PubMed ID: 19188575
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of gabapentin for uremic pruritus and restless legs syndrome in conservatively managed patients with chronic kidney disease.
    Cheikh Hassan HI, Brennan F, Collett G, Josland EA, Brown MA.
    J Pain Symptom Manage; 2015 Apr 03; 49(4):782-9. PubMed ID: 25220049
    [Abstract] [Full Text] [Related]

  • 14. Gabapentin and uremic pruritus in hemodialysis patients.
    Razeghi E, Eskandari D, Ganji MR, Meysamie AP, Togha M, Khashayar P.
    Ren Fail; 2009 Apr 03; 31(2):85-90. PubMed ID: 19212903
    [Abstract] [Full Text] [Related]

  • 15. Anticonvulsants to treat idiopathic restless legs syndrome: systematic review.
    Conti CF, Oliveira MM, Valbuza JS, Prado LB, Carvalho LB, Prado GF.
    Arq Neuropsiquiatr; 2008 Jun 03; 66(2B):431-5. PubMed ID: 18641891
    [Abstract] [Full Text] [Related]

  • 16. Management of restless legs syndrome with gabapentin (Neurontin).
    Mellick GA, Mellick LB.
    Sleep; 1996 Apr 03; 19(3):224-6. PubMed ID: 8723380
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.
    Burchell BJ.
    Neurology; 2003 May 13; 60(9):1558; author reply 1558. PubMed ID: 12743261
    [No Abstract] [Full Text] [Related]

  • 18. Restless legs syndrome: clinical experience with long-term treatment.
    Clavadetscher SC, Gugger M, Bassetti CL.
    Sleep Med; 2004 Sep 13; 5(5):495-500. PubMed ID: 15341896
    [Abstract] [Full Text] [Related]

  • 19. Gabapentin enacarbil for the treatment of restless legs syndrome (RLS).
    Burke RA, Faulkner MA.
    Expert Opin Pharmacother; 2011 Dec 13; 12(18):2905-14. PubMed ID: 22077768
    [Abstract] [Full Text] [Related]

  • 20. Gabapentin enacarbil for treatment of restless legs syndrome in adults.
    Hayes WJ, Lemon MD, Farver DK.
    Ann Pharmacother; 2012 Feb 13; 46(2):229-39. PubMed ID: 22298601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.